5th Circuit Holds Generic Drugmakers Not Required To Change Label
NEW ORLEANS — The Fifth Circuit U.S. Court of Appeals on May 24 found that three generic drug manufacturers did not have newly acquired risk information that could have been added...To view the full article, register now.
Already a subscriber? Click here to view full article